Provided by Tiger Trade Technology Pte. Ltd.

Zai Lab Ltd

24.14
-0.0300-0.12%
Post-market: 24.240.1000+0.41%19:30 EDT
Volume:663.51K
Turnover:16.09M
Market Cap:2.71B
PE:-14.18
High:24.62
Open:24.41
Low:24.06
Close:24.17
52wk High:34.72
52wk Low:15.96
Shares:112.35M
Float Shares:97.11M
Volume Ratio:0.79
T/O Rate:0.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7030
EPS(LYR):-1.6026
ROE:-26.91%
ROA:-14.75%
PB:4.47
PE(LYR):-15.06

Loading ...

UBS Keeps Their Buy Rating on Zai Lab Ltd (1ZLB)

TIPRANKS
·
Aug 08

Zai Lab Price Target Raised to $45.00/Share from $44.00 by Citigroup

Dow Jones
·
Aug 08

Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; End Week Up 2%

MT Newswires Live
·
Aug 07

US Stock Moves: Zai Lab Shares Surge Over 10% Extending Two-Day Rally

Stock News
·
Aug 07

Hong Kong Stocks Close: Hang Seng Rises 0.54%, Tech Index Gains 0.78%, PCB Concept Shares Surge, Biotech Stocks Rally, Z.AI Jumps Over 14%

Deep News
·
Aug 07

Positive Catalysts Drive Surge in Innovative Drug Sector; WuXi Series Leads as Huabao's Hong Kong Stock Connect Medical ETF Jumps 3%

Deep News
·
Aug 07

Zai Lab's Hong Kong Shares Hit Three-Month High on Quarterly Revenue Beat

Reuters
·
Aug 07

Hong Kong Market Movers: Zai Lab Ltd (09688) Surges Over 13% on Q2 Product Revenue Growth and Promising Pipeline Catalysts

Stock News
·
Aug 07

Zai Lab Shares Rise After Q2 Beat

MT Newswires Live
·
Aug 06

Zai Lab Ltd 2026 Second Quarter Product Revenue Rises 11% Sequentially as Zoci and ZL-1503 Lead Global Pipeline Acceleration

Stock News
·
Aug 06

Zai Lab Ltd Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Zai Lab reports Q2 EPS (46c), consensus (68c)

TIPRANKS
·
Aug 06

Zai Lab Q2 EPS $(0.46) Misses $(0.06) Estimate, Sales $105.751M Beat $105.323M Estimate

Benzinga Earnings
·
Aug 06

Press Release: Zai Lab Announces Second Quarter 2026 Financial Results and Recent Corporate Updates

Dow Jones
·
Aug 06

Zai Lab Receives FDA Orphan Drug Designation for Zocilurtatug Pelitecan in Neuroendocrine Carcinomas

MT Newswires Live
·
Aug 03

Earning Preview: Zai Lab Ltd Q2 revenue is expected to decrease by 16.97%, and institutional views are cautious

Earnings Agent
·
Jul 31

Asian Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading

MT Newswires Live
·
Jul 29

UBS Keeps Their Buy Rating on Zai Lab Ltd (1ZLB)

TIPRANKS
·
Jul 29

Press Release: Zai Lab to Announce Second Quarter 2026 Financial Results and Recent Corporate Updates on August 6, 2026

Dow Jones
·
Jul 22

US Stocks Close: Nasdaq Rises 1.3%, Philly Semiconductor Index Up Over 3%; Meta Denies Excess Computing Power, Tech Stocks Extend Rally, Chip and Optical Communications Shares Lead Gains

TradingKey
·
Jul 10